138 300

Cited 19 times in

Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.

Authors
Song, JH; Bae, JH; Rho, MI; Lee, SC
Citation
Retina (Philadelphia, Pa.), 30(6):945-951, 2010
Journal Title
Retina (Philadelphia, Pa.)
ISSN
0275-004X1539-2864
Abstract
PURPOSE: The purpose of this study was to evaluate the effect of intravitreal injection of bevacizumab on subretinal fluid associated with choroidal osteoma.



METHODS: In this retrospective noncomparative case series, eyes with serous retinal detachment involving the macula were treated with intravitreal injection of bevacizumab (1.25 mg/0.05 mL) and carefully followed-up with complete ophthalmic examination, including angiography and optical coherence tomography. The changes in best-corrected visual acuity and central foveal thickness were assessed by optical coherence tomography.



RESULTS: Six eyes received intravitreal injection of bevacizumab for serous retinal detachment. Only one eye had choroidal neovascularization associated with serous retinal detachment. The mean number of injections for the 6 eyes was 2.0 during the mean follow-up period of 11.3 months. The median logarithm of the minimum angle of resolution best-corrected visual acuity improved from 0.70 (Snellen equivalent, 20/100) at baseline to 0.30 (Snellen equivalent, 20/40; P = 0.043) at the final visit. The optical coherence tomography result also showed a significant reduction in central foveal thickness with a median central foveal thickness of 357.0 microm at baseline and 169.50 microm at the final visit (P = 0.028). The treatment was well tolerated, without ocular or systemic adverse events.



CONCLUSION: Intravitreal injection of bevacizumab for serous retinal detachment secondary to choroidal osteoma resulted in both visual and anatomical improvements.
MeSH terms
AdultAngiogenesis Inhibitors/*administration & dosageBody Fluids/drug effectsBone Neoplasms/*complications/pathologyChoroid Neoplasms/*complications/pathologyExudates and Transudates/drug effectsFemaleFluorescein AngiographyHumansInjectionsMaleMiddle AgedOsteoma/*complications/pathologyRetinal Detachment/*drug therapy/etiologyRetrospective StudiesTomography, Optical CoherenceVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity/physiologyVitreous Body
DOI
10.1097/IAE.0b013e3181c720ca
PMID
20531145
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Ophthalmology
AJOU Authors
송, 지훈
Full Text Link
Files in This Item:
Full-Text Not Available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse